CYP2C19*17 is associated with decreased breast cancer risk

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

JAMA · 2002 · 15.7K citations · Full text

Haploview: analysis and visualization of LD and haplotype maps

Jeffrey C. Barrett, Ben Fry, Julian Maller et al. · Bioinformatics · 2004 · 14.5K citations · Full text

Breast cancer and hormone-replacement therapy in the Million Women Study

Valerie Beral · The Lancet · 2003 · 3K citations

Breast Oncology, Endocrine-related Cancer, Medicine +10

Breast cancer and hormone-replacement therapy: the Million Women Study

Valerie Beral, Emily Banks, Gillian Reeves et al. · The Lancet · 2003 · 1.3K citations · Full text

Breast Oncology, Medicine, Gynecology +7

Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese.

Sara Moráis, G. Wilkinson, Joyce Blaisdell et al. · Molecular Pharmacology · 1994 · 750 citations